The benefit of dose-exposure-response modeling in the estimation of dose-response relationship and dose optimization: some theoretical and simulation evidence

TL;DR

This paper demonstrates that dose-exposure-response modeling can improve the efficiency of dose-response estimation and prediction in randomized trials, especially with sigmoid ER models, compared to direct dose-response modeling.

Contribution

The study provides theoretical and simulation evidence showing the advantages of DER modeling over DR modeling, including the use of control functions for unobserved confounders.

Findings

DER modeling with sigmoid ER models is more efficient than DR modeling.

Adjustment with control functions does not reduce efficiency in linear models.

Simulation quantifies efficiency gains across various scenarios.

Abstract

In randomized dose-finding trials, although drug exposure data form a part of key information for dose selection, the evaluation of the dose-response (DR) relationship often mainly uses DR data. We examine the benefit of dose-exposure-response (DER) modeling by sequentially modeling the dose-exposure (DE) and exposure-response (ER) relationships in parameter estimation and prediction, compared with direct DR modeling without PK data. We consider ER modeling approaches with control function (CF) that adjust for unobserved confounders in the ER relationship using randomization as an instrumental variable (IV). With both analytical derivation and a simulation study, we show that when the DE and ER models are linear, although the DER approach is moderately more efficient than the DR approach, with adjustment using CF, it has no efficiency gain (but also no loss). However, with some common ER models representing sigmoid curves, generally DER approaches with and without CF adjustment are more efficient than the DR approach. For response prediction at a given dose, the efficiency also depends on the dose level. Our simulation quantifies the benefit in multiple scenarios with different models and parameter settings. Our method can be used easily to assess the performance of randomized dose-finding trial designs.